BioSpace News Archive

Al Zahrawi Medical Supplies new distributor for Gulf Cooperation Council

BioTime, Inc. announced that Brian M. Culley, Chief Executive Officer, will be presenting at the Oppenheimer & Co. 29th Annual Healthcare Conference on March 20th, 2019 at 2:45pm Eastern Time at the Westin New York Grand Central in the Track 2 Room in New York, NY.

FLEXBUMIN 25% [Albumin (Human)], USP, 25% Solution is indicated for hypovolemia, hypoalbuminemia, (burns, Adult Respiratory Distress Syndrome (ARDS), and nephrosis), cardiopulmonary bypass surgery, and hemolytic disease of the newborn (HDN). Albumin is not indicated as an intravenous nutrient

Aimmune Therapeutics, Inc. announced that the Biologics License Application (BLA) for AR101 has been accepted for review by the U.S. Food and Drug Administration (FDA).

Blink Fitness, the premium quality, value-based gym, is thrilled to announce its expanded partnership with MSX by Michael Strahan (Pro Football Hall of Famer, broadcaster, and entrepreneur).

TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) (“TerrAscend” or “The Company”) today announced preliminary fourth quarter and full year revenue ending December 31st, 2018 of CAD$4.8 millionii and CAD$6.6 millioniii, respectively.

Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company dedicated to improving clinical outcomes and enhancing the cost-efficiency of colonoscopy, announced today that the U.S. Patent and Trademark Office (USPTO) has issued patent No. 10,179,202 titled, “Systems and methods for cleaning body cavities and for endoscopic steering,” which protects the Company’s flagship product, the Pure-Vu® System.

Check-Cap Ltd. (the “Company” or “Check-Cap”) (Nasdaq: CHEK) (Nasdaq: CHEKW), (Nasdaq: CHEKZ),today announced the appointment of Ms. Mira Rosenzweig as chief financial officer effective as of April 28, 2019.

Varex Imaging Corporation (Nasdaq: VREX) announced today that it is scheduled to make a presentation at the Sidoti & Company 2019 Spring Conference on Thursday, March 28, 2019 at 11:30 am Eastern Time.

Fluoride contributes to degenerative eye diseases such as cataracts, age related macular degeneration (AMD) and glaucoma, reports DT Waugh in the International Journal of Environmental Research and Public Health (March 2019), reports New York State Coalition Opposed to Fluoridation, Inc. (NYSCOF).